Patient Guide: Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 115 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05853575
Status: 🟢 Enrolling Now
Condition: Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
Phase: PHASE2

Where You Can Participate

This study is available at 115 locations across the country.

Top locations include:
  • • Santa Rosa, California
  • • Chicago, Illinois
  • • Minneapolis, Minnesota
  • • And 112 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) - Join Clinical Trial NCTNCT05853575

How to Join This Clinical Trial - NCTNCT05853575

Learn how to participate in this PHASE2 trial studying an investigational therapy for Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05853575 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 115 locations. Find a study site near you:

Clinical Research Site

Santa Rosa, California 95403 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60607 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Minneapolis, Minnesota 55417 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Kansas City, Missouri 64128 - United States

Status: RECRUITING

Clinical Research Site

Durham, North Carolina 27705 - United States

Status: RECRUITING

Clinical Research Site

Dallas, Texas 75216-7167 - United States

Status: RECRUITING

Clinical Research Site

Porto Alegre, Rio Grande Do Sul 90610-000 - Brazil

Status: RECRUITING

Clinical Research Site

Itajaí, Santa Catarina 88301-220 - Brazil

Status: RECRUITING

Clinical Research Site

Belo Horizonte, São Paulo 30360-680 - Brazil

Status: RECRUITING

Clinical Research Site

Salvador, 41950-610 - Brazil

Status: RECRUITING

And 105 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships